T

Tempus

Listed

Tempus leverages AI and genomic data to provide clinical decision support tools for personalized cancer care.

About

Tempus leverages AI and genomic data to provide clinical decision support tools for personalized cancer care.

Detailed overview

Tempus is an AI-powered precision medicine and genomic testing platform that has built what it describes as the world’s largest library of clinical and molecular data, along with an operating system to make that data accessible and useful, starting with cancer. The product is intended for healthcare providers, life sciences organizations, academic and research centers, and patients. For providers, key capabilities include oncology genomic profiling, algorithmic tests, EHR integration, clinical trial matching, digital pathology, and care pathway solutions across oncology, neurology, psychiatry, and cardiology. Specific cardiology solutions include ECG-AI and Tempus Pixel Cardio for identifying underdiagnosed and undertreated patients. For life sciences, the platform offers services such as sequencing, real-world data (RWD) via Tempus Lens, biological modeling, companion diagnostics, omics solutions, CRO services, clinical trial execution and enrollment, and AI-enabled algorithms including foundation models. For patients, the platform provides access to clinical trials in oncology and neurology/psychiatry. The technology is described as AI-enabled, with capabilities to accelerate discovery of novel targets and predict treatment effects, though specific performance claims are not detailed in the source text.

Website link is available on the Verified plan